Indian Petrochemical Industry

June 13, 2018

2017 has been a watershed year in many ways for the Indian economy, albeit not fully appreciated. One need's to look at some significant developments that have taken place in the last year to try and understand the impact on the business environment in India. This period saw two major developments - demonetisation and the introduction of GST. In addition, (over the last 12 months), the government introduced/operationalized key reforms aimed to address structural economic and transparency challenges that included the Insolvency and Bankruptcy Code (with a subsequent ordinance prohibiting exiting promoters or other bidders in default of their loan obligations from bidding for the companies under insolvency), Bank re-capitalization plan, Real Estate Regulation Act and Benami Transactions (Amendment).

Spotlight

Cell Medica

Cell Medica is committed to improving patients’ lives through the significant therapeutic potential of cellular immunotherapy. Our approach is to apply innovative technologies with the aim of improving the treatment of cancer. We have developed a business platform that has positioned Cell Medica as a leader in the manufacture and commercialization of cellular products. We collaborate with leading academic institutions to turn early stage innovations into medicinal products. Our highly dedicated team embrace the challenges that the field of cellular therapies presents. With patient benefits at the forefront of our activities, we overcome the considerable challenges through collaboration and the will to succeed.

OTHER WHITEPAPERS
news image

Methods, and Solutions for Chemical Treatment of Industrial Water and Wastewater

whitePaper | March 2, 2023

Fresh water is used in a broad range of process applications including boiler water and cooling system water treatment, as well as food and beverage process water treatment, among others. The resulting wastewater must then be properly treated before discharge into local sewer systems.

Read More
news image

Atmospheric Emissions and Reactions Observed from Megacities to Marine Areas

whitePaper | September 7, 2022

Atmospheric Emissions and Reactions Observed from Megacities to Marine Areas (AEROMMA) addresses emerging research needs in urban air quality.

Read More
news image

The Key to Efficient Carbon Capture: High-Performance Solvents

whitePaper | February 24, 2023

Solvents — specially formulated liquids that extract carbon dioxide from a mixture of other gases — have been used for decades, and are the most proven and mature carbon capture technologies on the market. They have been used in the petrochemical and fertiliser sectors for many years. Conventional solvents for carbon capture are amine-based, with the most common being monoethanolamine (MEA).

Read More
news image

ADVANCED DEMAND FLEXIBILITY MANAGEMENT

whitePaper | June 22, 2022

California’s electricity system is undergoing rapid transformation on the pathway to 100% renewable power, with the expected high penetration of renewables, electrification of buildings and transportation, and deployment of behind-the-meter (BTM) distributed energy resources (DERs).

Read More
news image

Considerations for Designing Supercritical CarbonDioxide Cycles and Turbomachinery

whitePaper | January 10, 2023

There are numerous benefits of supercritical carbon dioxide power generation systems, including reduced size and cost. Highly non-linear fluid properties enable the development of unique cycles targeted at specific applications.

Read More
news image

Liability and Coverage for the “Forever Chemicals”

whitePaper | May 11, 2022

For decades, BatesCarey has litigated insurance coverage disputes involving nationwide environmental pollution claims arising from an ever-evolving recognition of the toxicity of<br /> everyday products once thought to be innocuous, or even beneficial to society.

Read More

Spotlight

Cell Medica

Cell Medica is committed to improving patients’ lives through the significant therapeutic potential of cellular immunotherapy. Our approach is to apply innovative technologies with the aim of improving the treatment of cancer. We have developed a business platform that has positioned Cell Medica as a leader in the manufacture and commercialization of cellular products. We collaborate with leading academic institutions to turn early stage innovations into medicinal products. Our highly dedicated team embrace the challenges that the field of cellular therapies presents. With patient benefits at the forefront of our activities, we overcome the considerable challenges through collaboration and the will to succeed.

Events